Ventum Cap Mkts Weighs in on Cresco Labs FY2025 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBFFree Report) – Research analysts at Ventum Cap Mkts decreased their FY2025 earnings estimates for Cresco Labs in a research note issued on Wednesday, March 12th. Ventum Cap Mkts analyst A. Semple now forecasts that the company will earn ($0.09) per share for the year, down from their previous forecast of ($0.08). The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share.

Cresco Labs (OTCMKTS:CRLBFGet Free Report) last issued its quarterly earnings results on Friday, March 14th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). Cresco Labs had a negative net margin of 9.15% and a negative return on equity of 16.52%. The business had revenue of $176.00 million during the quarter, compared to the consensus estimate of $172.10 million.

Separately, Atb Cap Markets lowered Cresco Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, December 9th. Three equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $3.00.

Read Our Latest Stock Analysis on Cresco Labs

Cresco Labs Price Performance

Shares of CRLBF stock opened at $0.75 on Monday. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. Cresco Labs has a twelve month low of $0.70 and a twelve month high of $2.60. The firm has a fifty day simple moving average of $0.89 and a 200-day simple moving average of $1.20. The company has a market capitalization of $364.25 million, a PE ratio of -3.73 and a beta of 1.79.

Cresco Labs Company Profile

(Get Free Report)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Further Reading

Earnings History and Estimates for Cresco Labs (OTCMKTS:CRLBF)

Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.